Voltà-Durán E, Alba-Castellón L, Serna N, Casanova I, López-Laguna H, Gallardo A, Sánchez-Chardi A, Villaverde A, Unzueta U, Vázquez E, Mangues R. High-precision targeting and destruction of cancer-associated PDGFR-ß(+) stromal fibroblasts through self-assembling, protein-only nanoparticles.. Acta Biomaterialia. 2023; 170DOI:10.1016/j.actbio.2023.09.001. PMID:37683965. IF:9.400(Q1/1D).

Hernández-Sánchez, A, Ramiro, AV, Sträng, E, Turki, AT, Abáigar, M, Versluis, J, Thomas, I, Sobas, M, Elicegui, JM, Castellani, G, Benner, A, Azibeiro, R, Tettero, JM, Mecklenbrauck, R, Martínez-López, J, Pratcorona, M, Mills, KI, Sanz, G, Voso, MT, Sören, L, Röllig, C, Thiede, C, Metzeler, KH, Döhner, K, Heuser, M, Haferlach, T, Valk, PJM, Russell, N, Hernández-Rivas, JM, Huntly, B, Ossenkoppele, G, Döhner, H, Bullinger, L. Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study. LEUKEMIA. 2026; 40(2)DOI:10.1038/s41375-025-02851-9. PMID:41535568. IF:13.400(Q1/1D).

Charalampopoulou, S, Ramos-Campoy, S, Duran-Ferrer, M, Puiggros, A, Kamaso, J, Nguyen-Khac, F, Rigolin, GM, Cuneo, A, Collado, R, García-Serra, R, Haferlach, C, Ortega, M, Abrisqueta, P, Bosch, F, Zenz, T, Blanco, ML, Salgado, R, García-Malo, MD, Gimeno, E, Lopez-Guillermo, A, Campo, E, Etter, L, Schoumans, J, Espinet, B, Martin-Subero, JI. Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations. Hemasphere. 2026; 10(1)DOI:10.1002/hem3.70211. PMID:41523081. IF:14.600(Q1/1D).

Torres-Esquius, S, Gabarros-Subira, M, Rivero, ME, López, GR, Mañó, LG, Lopez, F, Fernandez, C, Guijarro, F, Díaz-Beyá, M, Canela, MP, Acha, P, Jáuregui, SN, Tuset, E, Palomo, L, Valcarcel, D, Albareda, FB, Jerez, A, Montoro, MJ. Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults. BLOOD. 2025; 146DOI:10.1182/blood-2025-4998. PMID:. IF:23.100(Q1/1D).

Turki, A, Dall'Olio, D, Carota, L, Polizzi, S, Morote, M, Della Porta, M, Zhao, YM, Lanino, L, Sobas, M, Zhao, YQ, Sanchez, AH, Eric, S, Gimenez, LT, Abáigar, M, Elicegui, JM, Ramiro, AV, Dohner, K, Tettero, J, Esteve, J, Martinez-Lopez, J, Metzeler, K, Haferlach, T, Lehmann, S, Pratcorona, M, Thiede, C, Versluis, J, Mecklenbrauck, R, Heuser, M, Benner, A, Huntley, B, Rivas, JMH, Ossenkoppele, G, Döhner, H, Castellani, G, Bullinger, L. Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia. BLOOD. 2025; 146DOI:10.1182/blood-2025-451. PMID:. IF:23.100(Q1/1D).

Ramil, G, Artigas, A, Giné, A, Oñate, G, Castellet, H, Díaz-Beyá, M, Tormo, M, Cervera, M, Coll, R, Martínez-Serra, J, Vives, S, García-Guiñón, A, Mascaró, M, Gómez, L, García-Avila, S, Vall-Llovera, F, Gómez, R, Arnan, M, Salamero, O, Garrido, A, Esteve, J, Nomdedéu, J, Sierra, J, Pratcorona, M. Comparative analysis of NGS and dPCR for measurable residual disease monitoring in intensively treated acute myeloid leukemia patients. ANNALS OF HEMATOLOGY. 2025; 104(1)DOI:. PMID:. IF:2.400(Q2/5D).

Clavé, S, Montironi, C, Oliveras, G, Varela, M, Catasús, L, Sese, M, Hernández-Gallego, A, Teixido, C, Urbizu, A, González-Vidal, A, Pijuan, L, Sansano, I, Baixeras, N, Vásquez, C, Fuertes, B, Sánchez-Güerri, I, Lopez-Vilaro, L, Mate, JL, Bellosillo, B, Hernández-Losa, J, Muñoz-Mármol, AM. Complementary Role of IHC in ALK Fusion Detection: A Validation Study of NSCLC NGS-Based Screening in Seven Laboratories. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).

Herrera, IC, Fabregó, IE, Cols, LC, Lladó, MC, Vidal, AG, Martín, LF, Mariscal, IE, Arango, SMR, Metrallé, SCS, Alcañiz, AG. Prognostic significance of genetic biomarkers in glioblastoma IDH wild-type: a retrospective survival analysis. VIRCHOWS ARCHIV. 2025; 487DOI:. PMID:. IF:3.100(Q2/3D).